When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time)
Health & MedicineOne-Off3mManifold MarketsSem KYCDados de resolução verificadosRazoavelmente calibradoPrevisão da comunidade atualDecember 2026 36%Líder entre 7 opções
Previsores
6
Tipo de pergunta
multiple choice
Metodologia
Play-money forecasting platform
Tipo de fonte
Previsão
Variação 7d
0.0 pts
Dados do mercado
Atualizado há 1 hora
Atrasado7/07/26, 22:11 UTC2/01/27, 04:59 UTC
Tendências
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
Intoxicating hemp-derived THC products federally banned in U.S. by end of 2026?
Manifold MarketsWill hemp-derived CBN sleep products still be federally legal as “hemp” on Nov 12, 2026?
Manifold MarketsWill Lego release a set for 'Fountain' by Duchamp by the end of 2030?
Manifold MarketsEbola pandemic in 2026?
PolymarketHantavirus pandemic in 2026?
PolymarketFDA approves skin cancer vaccine by which date?
PolymarketRegras
The FDA is under pressure to approve nicotine products under the PMTA (Premarket Tobacco Product Application) pathway.
- They have permitted products without FDA marketing authorization to remain available while the applications are under review.
- Resolution Criteria: Resolves to the FDA official website which lists authorizations
- Resolution Sources: .gov websites, official press releases
Mercados abertos
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No-0.3pt97%
- Yes+0.3pt3%
- Volume total
- € 15,6 mi
- Volume 24h
- € 35,6 mil
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.9pt3%
- Volume total
- € 1,6 mi
- Volume 24h
- € 5,2 mil
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+4.0pt65%
- September41%
- June28%
- Volume total
- € 83,5 mil
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-1.0pt96%
- Above 6000-4.0pt58%
+2 mais resultados
- Volume total
- € 864,2 mil
- Volume 24h
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volume total
- € 915,8 mil
- Volume 24h
- € 1,5 mil
KALSHIWhen will the FDA approve Intellia Therapeutics' lonvo-z?
- Before July 2027+67.0pt97%
- Before 202872%
- Before October 202752%
- Volume total
- € 4,2 mil
- Volume 24h
- Will 3 mg THC beverages be federally legal to sell?
- Measles cases in U.S. in 2026?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- When will the FDA reclassify BPC-157 to Category 1?
- Ebola pandemic in 2026?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- Will the FDA approve CagriSema?
Perguntas frequentes
- Quais são as probabilidades atuais de When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time)?
- A Manifold Markets cota December 2026 em 36% em 9 de setembro de 2026.
- Quando When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time) é resolvido?
- When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time) deverá ser resolvido em 2 de janeiro de 2027.
- Como When will the FDA release the next set of authorizations for marketing of alternative nicotine products? (Eastern Time) é liquidado?
- A Manifold Markets liquida este mercado da seguinte forma: The FDA is under pressure to approve nicotine products under the PMTA (Premarket Tobacco Product Application) pathway.